To date, there have
been no major impacts to the business and accordingly the 25% pay reduction will be removed from
1 September 2020
But WP, milesotnes have not been reached and the company is still yet to make a profit whilst you CEO pay is double that what is sld be based on peer sized map cap Co's that actually make a profit. If the company misses 3+mil surely the board can go without too?
Under the Agreement, Anteris was to receive up to $A3.73M if gross revenue from LeMaitre
CardioCel® and VascuCel® product sales exceeded $A29.8M in the first 12 months (11 October 2020)
or $A1.8M if gross revenue from product sales exceed $A22.4M in the first 12 months. ($A amounts
calculated at the then $US1/$A0.67 FX rate.)
Anteris still expects the $US0.65M post-closing instalment payment on the first anniversary of the
Agreement this October 2020. A second, equal post-closing instalment is due on the Agreement’s
second anniversary.
- Forums
- ASX - By Stock
- AVR
- Ann: Operations update
Ann: Operations update, page-2
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.71 |
Change
0.010(0.06%) |
Mkt cap ! $301.9M |
Open | High | Low | Value | Volume |
$16.00 | $16.01 | $15.49 | $3.254M | 230.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $15.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.20 | 700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 15.700 |
1 | 437 | 15.550 |
1 | 296 | 15.510 |
2 | 1150 | 15.500 |
2 | 652 | 15.490 |
Price($) | Vol. | No. |
---|---|---|
16.200 | 700 | 2 |
16.500 | 63 | 1 |
16.600 | 500 | 1 |
17.000 | 550 | 1 |
17.100 | 900 | 1 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |